Company Aarey Drugs & Pharmaceuticals Limited

AAREYDRUGS

INE198H01019

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:53 07/06/2024 BST			5-day change	1st Jan Change
45.9 ^INR	+4.44%		-1.54%	-9.16%

05-30	Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
03-27	Aarey Drugs & Pharmaceuticals Limited announced that it has received INR 106.581598 million in funding from Black Hawk Properties Private Limited, Rajan Dental Institute Private Limited, Marygold Health And Education Private Limited, Riddhi Trade Solutions Private Limited, Karan Monomer's Private Limited, Watco Chennai Real Estates Private Limited and other investors	CI

Aarey Drugs and Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing and trading of drugs and pharmaceuticals. The Company is in active pharmaceutical ingredients (API)/bulk drug manufacturing and offers a range of products for various industrial applications. Its products include N-Methyl Urea, Mefenamic acid, Doxaphylline, Lumefantrine, Nimesulide, Albendazole, Carbamazepine and Oxcarbazepine. The Company's chemical and solvents include Aeromatics Chemical, Chemical acid, Chlor Alkali, Industrial Alchols, Industrial Ketones, Glycols and Glycol Ethers, Fiber Intermediates, Industrial Amines, Acetates and Esters, Industrial Oleochemicals, Chlorinated Solvents, Industrial Intermediates, Industrial Olefines, Industrial Phosphates, Industrial Fertilizers, Industrial Monomers and Industrial Chemicals. Its chemical acid products include Acetic acid, Citric acid, Formic acid and Hydrochloric acid.

Number of employees: 132

INR in Million	2022	Weight	2023	Weight	Delta
Active Pharmaceutical Ingredients 100.0 %	4,927	100.0 %	4,190	100.0 %	-14.96%

INR in Million	2022	Weight	2023	Weight	Delta
India 100.0 %	4,927	100.0 %	4,190	100.0 %	-14.96%

Managers	Title	Age	Since
Mihir Rajesh Ghatalia CEO	Chief Executive Officer	40	01/08/04
Mira Mihir Ghatalia DFI	Director of Finance/CFO	-	03/01/21
Preeti Paresh Rathi CMP	Compliance Officer	-	28/01/20
Vilas Lokhande CTO	Chief Tech/Sci/R&D Officer	-	-

Members of the board	Title	Age	Since
Mihir Rajesh Ghatalia CEO	Chief Executive Officer	40	01/08/04
Lalit Radhakrishna Tulsiani BRD	Director/Board Member	66	01/12/04
Chetan Kiritbhai Mehta BRD	Director/Board Member	55	01/06/08
Nimit Rajesh Ghatalia BRD	Director/Board Member	28	30/06/20
Anil Mandal BRD	Director/Board Member	32	31/10/18
Bina Rajesh Ghatalia BRD	Director/Board Member	63	08/10/23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	28,054,303	13,356,860 ( 47.61 %)	0	47.61 %

Aarey Drugs & Pharmaceuticals Ltd.

203/4, Sahakar Bhavan 340/348, Narshi Natha Street

400009, Mumbai

+91 22 2345 5543

http://www.aareydrugs.com

address Aarey Drugs & Pharmaceuticals Limited(AAREYDRUGS)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
AAREY DRUGS & PHARMACEUTICALS LIMITED	-9.16%	15.42M
ELI LILLY AND COMPANY	+45.82%	765B
NOVO NORDISK A/S	+40.95%	632B
JOHNSON & JOHNSON	-6.16%	354B
MERCK & CO., INC.	+19.86%	331B
ABBVIE INC.	+9.32%	299B
ASTRAZENECA PLC	+18.45%	248B
NOVARTIS AG	+11.88%	216B
ROCHE HOLDING AG	-0.78%	219B
AMGEN INC.	+5.90%	164B

Other Pharmaceuticals